Abstract:Background: Forkhead box P3+ (FOXP3 +) regulatory T cells (Tregs) are a subset of lymphocytes, critical for the maintenance of immune homeostasis. Loss-of-function mutations of the FOXP3 gene in animal models and humans results in loss of differentiation potential into Treg cells and are responsible for several immune-mediated inflammatory diseases. Strategies of increasing FOXP3 expression represent a potential approach to increase the pool of Tregs within the lymphocyte population and may be employed in therapies of diverse autoimmune conditions. In the present study, a dCas9 CRISPR-based method was systematically employed to achieve upregulation and sustained high expression of endogenous FOXP3 in HEK293 and human Jurkat T cell lines through targeting of the core promotor, three known regulatory regions of the FOXP3 gene (CNS1-3), and two additional regions selected through extensive bioinformatics analysis (Cage1 and Cage2). Results: Using an activator-domain fusion based dCas9 transcription activator, robust upregulation of FOXP3 was achieved, and an optimal combination of single guide RNAs was selected, which exerted an additive effect on FOXP3 gene upregulation. Simultaneous targeting of FOXP3 and EOS, a transcription factor known to act in concert with FOXP3 in initiating a Treg phenotype, resulted in upregulation of FOXP3 downstream genes CD25 and TNFR2. When compared to ectopic expression of FOXP3 via plasmid electroporation, upregulation of endogenous FOXP3 via the Cas9-based method resulted in prolonged expression of FOXP3 in Jurkat cells. Conclusions: Transfection of both HEK293 and Jurkat cells with dCas9-activators showed that regulatory regions downstream and upstream of FOXP3 promoter can be very potent transcription inducers in comparison to targeting the core promoter. While introduction of genes by conventional methods of gene therapy may involve a risk of insertional mutagenesis due to viral integration into the genome, transient up- or down-regulation of transcription by a CRISPR-dCas9 approach may resolve this safety concern. dCas9-based systems provide great promise in DNA footprint-free phenotype perturbations (perturbation without the risk of DNA damage) to drive development of transcription modulation-based therapies.

CRISPR PERSIST-On enables heritable and fine-tunable human gene activation

Discovery of hypercompact epigenetic modulators for persistent CRISPR-mediated gene activation

CRISPR RNA–guided activation of endogenous human genes

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

PERSIST platform provides programmable RNA regulation using CRISPR endoRNases

In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

CRISPRoff epigenetic editing for programmable gene silencing in human cells without DNA breaks

A New Class of Temporarily Phenotypic Enhancers Identified by CRISPR/Cas9-mediated Genetic Screening.

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

CRISPRa-mediated FOXP3 gene upregulation in mammalian cells

Gene Activation by a CRISPR-assisted Trans Enhancer

Mini and Enhanced CRISPR Activators for Cancer Therapies

A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation

One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes.

CRISPRe: An innate transcriptional enhancer for endogenous genes in CRISPR-Cas immunity

Spatiotemporal control of CRISPR/Cas9 gene editing

CRISPR perfect adaptation for robust control of cellular immune and apoptotic responses

Generation of Cell Lines Stably Expressing a dCas9-Fusion or sgRNA to Address Dynamics of Long-Term Effects of Epigenetic Editing

Multiplexed activation in mammalian cells using a split-intein CRISPR/Cas12a based synthetic transcription factor